Androstendiona

Volver al artículo.

Referencias para el artículo

  1. Mahesh VB, Greenblatt RB. The in vivo conversion of dehydroepiandrosterone and androstenedione to testosterone in the human. Acta Endocrinologica 1962;41:400-6.
  2. Leder BZ, Longcope C, Catlin DH, et al. Oral androstenedione administration and serum testosterone concentrations in young men. JAMA 2000;283:779-82.
  3. King DS, Sharp RL, Vukovich MD, et al. Effect of oral androstenedione on serum testosterone and adaptations to resistance training in young men: a randomized controlled trial. JAMA 1999;281:2020-8.
  4. Rasmussen BB, Volpi E, Gore DC, Wolfe RR. Androstenedione does not stimulate muscle protein anabolism in young healthy men. J Clin Endocrinol Metab 2000;85:55-9.
  5. Rasmussen BB, Volpi E, Gore DC, Wolfe RR. Androstenedione does not stimulate muscle protein anabolism in young healthy men. J Clin Endocrinol Metab 2000;85:55-9.
  6. King DS, Sharp RL, Vukovich MD, et al. Effect of oral androstenedione on serum testosterone and adaptations to resistance training in young men: a randomized controlled trial. JAMA 1999;281:2020-8.
  7. Miyamoto H, Yeh S, Lardy H, et al. Delta5-androstenediol is a natural hormone with androgenic activity in human prostate cancer cells. Proc Natl Acad Sci U S A 1998;95:11083-8.
  8. Padgett DA, Sheridan JF. Androstenediol (AED) prevents neuroendocrine-mediated suppression of the immune response to an influenza viral infection. J Neuroimmunol 1999;98:121-9.
  9. Lea CK, Moxham V, Reed MJ, Flanagan AM. Androstenedione treatment reduces loss of cancellous bone volume in ovariectomised rats in a dose-responsive manner and the effect is not mediated by oestrogen. J Endocrinol 1998;156:331-9.
  10. Saden-Krehula M, Tajic M, Kolbah D. Testosterone, epitestosterone and androstenedione in the pollen of Scotch Pine P. silvestris L. Experientia 1993;27:108–9.
  11. Longcope C. Androgen metabolism and the menopause. Semin Reprod Endocrinol 1998;16:111–5.
  12. Jiroutek MR, Chen MH, Johnston CC, Longcope C. Changes in reproductive hormones and sex hormone-binding globulin in a group of postmenopausal women measured over 10 years. Menopause 1998;5:90–4.
  13. Szymczak J, Milewicz A, Thijssen JH, et al. Concentration of sex steroids in adipose tissue after menopause. Steroids 1998;63:319–21.
  14. De Lorenzo A, Lello S, Andreoli A, et al. Body composition and androgen pattern in the early period of postmenopause. Gynecol Endocrinol 1998;12:171–7.
  15. Vilarinho ST, Costallat LT. Evaluation of the hypothalamic-pituitary-gonadal axis in males with systemic lupus erythematosus. J Rheumatol 1998;25:1097–103.
  16. King DS, Sharp RL, Vukovich MD, et al. Effect of oral androstenedione on serum testosterone and adaptations to resistance training in young men: a randomized controlled trial. JAMA 1999;281:2020–8.
  17. Habenicht UF, Schwarz K, Neumann F, El Etreby MF. Induction of estrogen-related hyperplastic changes in the prostate of the cynomolgus monkey (Macaca fascicularis) by androstenedione and its antagonization by the aromatase inhibitor 1-methyl-androsta-1,4-diene-3,17-dione. Prostate 1987;11:313–26.